Non-MRI-conditional implantable cardioverter defibrillators appropriately treat detected tachyarrhythmias after MRI
By Elana Gotkine HealthDay Reporter
TUESDAY, Jan. 31, 2023 (HealthDay News) — For patients with non-magnetic resonance imaging (MRI)-conditional implantable cardioverter defibrillators (ICDs), these ICDs still appropriately treat detected tachycardia after MRI, according to a study published online Jan. 31 in the Annals of Internal Medicine.
Joshua Ra, M.D., from the University of California San Francisco, and colleagues conducted a prospective cohort study to examine whether non-MRI-conditional ICDs have preserved shock function of arrhythmias after MRI among 629 patients enrolled consecutively between February 2003 and January 2015 who underwent 813 total MRI examinations at 1.5 Tesla.
The researchers detected 4,177 arrhythmia episodes and 97 patients received ICD shocks during a median follow-up of 2.2 years from MRI to latest available ICD interrogation before generator or lead exchange in 536 patients. Overall, 61 patients (10 percent) had 130 spontaneous ventricular tachycardia or fibrillation events terminated by ICD shocks. Thirty-three percent of patients (210 patients) were known to have died (median, 1.7 years from MRI to death); cardiac arrhythmia deaths were reported in three patients, where shocks were indicated without direct evidence of device dysfunction.
“Our findings are consistent with the accumulating evidence that 1.5-Tesla MRI scans do not induce clinically significant functional changes in non-MRI-conditional ICDs,” the authors write.
Copyright © 2023 HealthDay. All rights reserved.
